Skip to main content
Erschienen in: Clinical Rheumatology 6/2019

09.02.2019 | Original Article

Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome

verfasst von: Doaa Hassan Sayed Attia, Rasha A. Abdel Noor, Shaimaa Salah

Erschienen in: Clinical Rheumatology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The frequency of different vasculitides and their characteristics vary among different regions. The identification of geographic disparities of disease phenotypes helps the development of international criteria, allowing the classification of patients of different ethnicities. This study aimed to describe the frequency, characteristics, course, response to treatment, and outcome of the different adulthood vasculitides in Egypt.

Methods

This was a multicenter study in which the medical records of adult Egyptian patients diagnosed with vasculitis between 2002 and 2018 were retrospectively reviewed.

Results

The most frequent vasculitides in Egypt were Behçet’s disease (76%), hepatitis C virus vasculitis (13.9%), and granulomatosis with polyangiitis (3.9%). Most patients (73.8%) had a major event at the time of diagnosis. Generalized granulomatosis with polyangiitis was more common than the localized type (90% versus 10%, respectively). The aortic arch and its branches were the most common affected sites of Takayasu arteritis. Of vasculitides, Behçet’s disease and giant cell arteritis were associated with the greatest rates of relapse (62.7% and 33.3%, respectively). Delayed diagnosis and permanent organ damage were reported in 69.9% and 68.9% of patients, respectively. A low mortality rate was noted (1.3%).

Conclusions

The most common types of adulthood vasculitides in Egypt are Behçet’s disease, hepatitis C virus vasculitis, and granulomatosis with polyangiitis. Major organ involvement is frequent. Delayed diagnosis and permanent organ damage are common.
Literatur
1.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11CrossRefPubMed Jennette JC, Falk RJ, Bacon PA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11CrossRefPubMed
2.
3.
Zurück zum Zitat Watts RA (2005) Epidemiology of vasculitis in India-what is known? J Indian Rheumatol Assoc 13:8–15 Watts RA (2005) Epidemiology of vasculitis in India-what is known? J Indian Rheumatol Assoc 13:8–15
5.
Zurück zum Zitat Arend WP, Michel BA, Bloch DA (1990) American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed Arend WP, Michel BA, Bloch DA (1990) American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed
6.
Zurück zum Zitat Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093CrossRefPubMed Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093CrossRefPubMed
7.
Zurück zum Zitat Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis. Arthritis Rheum 33(8):1101–1107CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis. Arthritis Rheum 33(8):1101–1107CrossRefPubMed
8.
Zurück zum Zitat Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100CrossRefPubMed Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100CrossRefPubMed
9.
Zurück zum Zitat Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, Fries JF, Hunder GG, Leavitt RY, Lie JT (1990) American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33:1108–1113CrossRefPubMed Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, Fries JF, Hunder GG, Leavitt RY, Lie JT (1990) American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33:1108–1113CrossRefPubMed
10.
Zurück zum Zitat International Team for the Revision of International Criteria for Behçet’s Disease (2008) Clinical manifestations of Behçet’s disease. The ITR-ICBD report. Clin Exp Rheumatol 26(Suppl 50):S1–S18 International Team for the Revision of International Criteria for Behçet’s Disease (2008) Clinical manifestations of Behçet’s disease. The ITR-ICBD report. Clin Exp Rheumatol 26(Suppl 50):S1–S18
11.
Zurück zum Zitat Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J et al (2002) Standardized nomenclature for glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61(8):718–722CrossRefPubMedPubMedCentral Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J et al (2002) Standardized nomenclature for glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61(8):718–722CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Boki KA, Dafni U, Karpouzas GA, Papasteriades C, Papasteriades C, Drosos AA et al (1997) Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol 36(10):1059–1066CrossRefPubMed Boki KA, Dafni U, Karpouzas GA, Papasteriades C, Papasteriades C, Drosos AA et al (1997) Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol 36(10):1059–1066CrossRefPubMed
13.
Zurück zum Zitat Chaudhry IA, Shamsi FA, Elzaridi E, Arat YO, Bosley TM, Riley FC (2007) Epidemiology of giant-cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol 91:715–718CrossRefPubMedPubMedCentral Chaudhry IA, Shamsi FA, Elzaridi E, Arat YO, Bosley TM, Riley FC (2007) Epidemiology of giant-cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol 91:715–718CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Khalifa M, Karmani M, Jaafoura NG, Kaabia N, Letaief AO, Bahri F; Study Group of GCA in Tunisia (2009) Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med 20:208–212 Khalifa M, Karmani M, Jaafoura NG, Kaabia N, Letaief AO, Bahri F; Study Group of GCA in Tunisia (2009) Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med 20:208–212
15.
Zurück zum Zitat Shahin AA, Zayed HS, Elrefai RM, Taher H, Elsaie A, Senara SH, Fathi HM, Omar G, Abd Elazeem MI (2018) The distribution and outcome of vasculitic syndromes among Egyptians: a multi-centre study including 630 patients. Egyptian Rheumatol 40(4):243–248CrossRef Shahin AA, Zayed HS, Elrefai RM, Taher H, Elsaie A, Senara SH, Fathi HM, Omar G, Abd Elazeem MI (2018) The distribution and outcome of vasculitic syndromes among Egyptians: a multi-centre study including 630 patients. Egyptian Rheumatol 40(4):243–248CrossRef
16.
Zurück zum Zitat Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2015) Behçet's syndrome: a critical digest of the 2014–2015 literature. Clin Exp Rheumatol 33:S3–S14PubMed Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2015) Behçet's syndrome: a critical digest of the 2014–2015 literature. Clin Exp Rheumatol 33:S3–S14PubMed
17.
Zurück zum Zitat Mohammad A, Mandl T, Sturfelt G, Segelmark M (2013) Incidence, prevalence and clinical characteristics of Behçet’s disease in southern Sweden. Rheumatology (Oxford) 52(2):304–310CrossRef Mohammad A, Mandl T, Sturfelt G, Segelmark M (2013) Incidence, prevalence and clinical characteristics of Behçet’s disease in southern Sweden. Rheumatology (Oxford) 52(2):304–310CrossRef
18.
Zurück zum Zitat Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H et al (2007) Ocular features of Behçet’s disease: an international collaborative study. Br J Ophthalmol 91(12):1579–1582CrossRefPubMedPubMedCentral Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H et al (2007) Ocular features of Behçet’s disease: an international collaborative study. Br J Ophthalmol 91(12):1579–1582CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Joshi VR, Mittal G (2006) Vasculitis—Indian perspective. J Assoc Physicians India 54(Suppl):12–14PubMed Joshi VR, Mittal G (2006) Vasculitis—Indian perspective. J Assoc Physicians India 54(Suppl):12–14PubMed
20.
Zurück zum Zitat Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M et al (2010) Behçet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367–373CrossRefPubMed Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M et al (2010) Behçet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367–373CrossRefPubMed
21.
22.
Zurück zum Zitat Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B (2010) Behçet’s disease: from east to west. Clin Rheumatol 29(8):823–833CrossRefPubMed Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B (2010) Behçet’s disease: from east to west. Clin Rheumatol 29(8):823–833CrossRefPubMed
23.
Zurück zum Zitat Ames PRJ, Steuer A, Pap A, Denman AM (2001) Thrombosis in Behçet’s disease: a retrospective survey from a single UK centre. Rheumatology 40(6):652–655CrossRefPubMed Ames PRJ, Steuer A, Pap A, Denman AM (2001) Thrombosis in Behçet’s disease: a retrospective survey from a single UK centre. Rheumatology 40(6):652–655CrossRefPubMed
24.
Zurück zum Zitat Joseph FG, Scolding NJ (2007) Neuro-Behçet’s disease in Caucasians: a study of 22 patients. Eur J Neurol 14(2):174–180CrossRefPubMed Joseph FG, Scolding NJ (2007) Neuro-Behçet’s disease in Caucasians: a study of 22 patients. Eur J Neurol 14(2):174–180CrossRefPubMed
25.
Zurück zum Zitat Sansonno D, Dammacco F (2005) Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227–236CrossRefPubMed Sansonno D, Dammacco F (2005) Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227–236CrossRefPubMed
26.
Zurück zum Zitat Mohammed RH, ElMakhzangy HI, Gamal A, Mekky F, El Kassas M, Mohammed N et al (2010) Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29(12):1373–1380CrossRefPubMed Mohammed RH, ElMakhzangy HI, Gamal A, Mekky F, El Kassas M, Mohammed N et al (2010) Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29(12):1373–1380CrossRefPubMed
27.
Zurück zum Zitat Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sène D et al (2012) Low 25-hydroxyvitamin D serum levels correlate with the presence of extrahepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford) 51(11):2083–2090CrossRef Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sène D et al (2012) Low 25-hydroxyvitamin D serum levels correlate with the presence of extrahepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford) 51(11):2083–2090CrossRef
28.
Zurück zum Zitat Johnson R, Gretch D, Yamabe H, Hart J, Bacchi CE, Hartwell P et al (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470CrossRefPubMed Johnson R, Gretch D, Yamabe H, Hart J, Bacchi CE, Hartwell P et al (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470CrossRefPubMed
29.
Zurück zum Zitat Terrier B, Semoun O, Saadoun D, Font J (2011) Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum 63(6):1748–1757CrossRefPubMed Terrier B, Semoun O, Saadoun D, Font J (2011) Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum 63(6):1748–1757CrossRefPubMed
30.
Zurück zum Zitat Gamarra AI, Coral P, Quintana G, Toro CE, Flores LF, Matteson EL et al (2010) History of primary vasculitis in Latin America. Med Sci Monit 16(3):RA58–RA72 Gamarra AI, Coral P, Quintana G, Toro CE, Flores LF, Matteson EL et al (2010) History of primary vasculitis in Latin America. Med Sci Monit 16(3):RA58–RA72
31.
Zurück zum Zitat Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, Ito C, Kusano E, Yamagata M, Ikeda K, Kashiwakuma D, Iwamoto I, Westman K, Jayne D (2014) Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 41:325–333CrossRefPubMed Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, Ito C, Kusano E, Yamagata M, Ikeda K, Kashiwakuma D, Iwamoto I, Westman K, Jayne D (2014) Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 41:325–333CrossRefPubMed
32.
Zurück zum Zitat Handa R, Wali JP, Biswas A, Aggarwal P, Wig N (1997) Wegener’s granulomatosis- a clinicopathologic study. J Assoc Physicians India 45:536–539 Handa R, Wali JP, Biswas A, Aggarwal P, Wig N (1997) Wegener’s granulomatosis- a clinicopathologic study. J Assoc Physicians India 45:536–539
33.
Zurück zum Zitat Ishida Y, Katada A, Kishibe K, Imada M, Hayashi T, Nonaka S, Harabuchi Y (2004) Wegener’s granulomatosis with otolaryngological symptoms. Practica Oto-Rhino-Laryngol 97:997–1005CrossRef Ishida Y, Katada A, Kishibe K, Imada M, Hayashi T, Nonaka S, Harabuchi Y (2004) Wegener’s granulomatosis with otolaryngological symptoms. Practica Oto-Rhino-Laryngol 97:997–1005CrossRef
34.
Zurück zum Zitat Furuta S, Chaudhry AN, Arimura Y, Dobashi H, Fujimoto S, Homma S, Rasmussen N, Jayne DR (2017) Comparison of the phenotype and outcome of granulomatosis with polyangiitis between UK and Japanese cohorts. J Rheumatol 44:216–222CrossRefPubMed Furuta S, Chaudhry AN, Arimura Y, Dobashi H, Fujimoto S, Homma S, Rasmussen N, Jayne DR (2017) Comparison of the phenotype and outcome of granulomatosis with polyangiitis between UK and Japanese cohorts. J Rheumatol 44:216–222CrossRefPubMed
35.
Zurück zum Zitat Arulkumaran N, Periselneris N, Gaskin G, Strickland N, Ind PW, Pusey CD, Salama AD (2011) Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 50:2035–2043CrossRef Arulkumaran N, Periselneris N, Gaskin G, Strickland N, Ind PW, Pusey CD, Salama AD (2011) Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 50:2035–2043CrossRef
36.
Zurück zum Zitat Oh JS, Lee CK, Kim YG, Nah SS, Moon HB, Yoo B (2009) Clinical features and outcomes of microscopic polyangiitis in Korea. J Korean Med Sci 24:269–274CrossRefPubMedPubMedCentral Oh JS, Lee CK, Kim YG, Nah SS, Moon HB, Yoo B (2009) Clinical features and outcomes of microscopic polyangiitis in Korea. J Korean Med Sci 24:269–274CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919–929CrossRefPubMed Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919–929CrossRefPubMed
38.
Zurück zum Zitat Numano F (2002) The story of Takayasu arteritis. Rheumatology (Oxford) 41:103–106CrossRef Numano F (2002) The story of Takayasu arteritis. Rheumatology (Oxford) 41:103–106CrossRef
39.
Zurück zum Zitat Numano F (1997) Differences in clinical presentation and outcome in different countries for Takayasu’s arteritis. Curr Opin Rheumatol 9:12–15CrossRefPubMed Numano F (1997) Differences in clinical presentation and outcome in different countries for Takayasu’s arteritis. Curr Opin Rheumatol 9:12–15CrossRefPubMed
40.
Zurück zum Zitat Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, Ishibashi-Ueda H, Kobayashi J, Yagihara T, Kitamura S (2008) Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circ 118:2738–2747CrossRef Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, Ishibashi-Ueda H, Kobayashi J, Yagihara T, Kitamura S (2008) Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circ 118:2738–2747CrossRef
41.
Zurück zum Zitat Hellmann DB (2017) Giant cell arteritis, polymyalgia rheumatica, and Takayasu’s arteritis. In: Firestein GS, Budd RC, Gabriel SE, Mcinnes LB, O'Dell JR et al (eds) Kelley & Firestein’s textbook of rheumatology, 10th edn. Elsevier, Philadelphia, pp 1520–1540CrossRef Hellmann DB (2017) Giant cell arteritis, polymyalgia rheumatica, and Takayasu’s arteritis. In: Firestein GS, Budd RC, Gabriel SE, Mcinnes LB, O'Dell JR et al (eds) Kelley & Firestein’s textbook of rheumatology, 10th edn. Elsevier, Philadelphia, pp 1520–1540CrossRef
42.
Zurück zum Zitat Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRef Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRef
43.
Zurück zum Zitat McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP (1989) Hepatitis B-associated polyarteritis nodosa in Alaskan eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 9:97–101CrossRefPubMed McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP (1989) Hepatitis B-associated polyarteritis nodosa in Alaskan eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 9:97–101CrossRefPubMed
44.
Zurück zum Zitat Handa R, Wali JP, Gupta SD, Dinda AK, Aggarwal P, Wig N, Biswas A (2001) Classic polyarteritis nodosa and microscopic polyangiitis-a clinicopathologic study. J Assoc Physicians India 49:314–319PubMed Handa R, Wali JP, Gupta SD, Dinda AK, Aggarwal P, Wig N, Biswas A (2001) Classic polyarteritis nodosa and microscopic polyangiitis-a clinicopathologic study. J Assoc Physicians India 49:314–319PubMed
Metadaten
Titel
Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome
verfasst von
Doaa Hassan Sayed Attia
Rasha A. Abdel Noor
Shaimaa Salah
Publikationsdatum
09.02.2019
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 6/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04441-4

Weitere Artikel der Ausgabe 6/2019

Clinical Rheumatology 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.